Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIFIT Study: Intravenous iron and tranexamic acid to reduce transfusion in hip fracture patients
2016-003087-40Phase 3Terminated
- Sponsor
- UHangers
- Start
- Nov 2016
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of ferric derisomaltose and tranexamic acid in hip fracture (4 arms), sponsored by UHangers. Started Nov 2016; status: terminated.
02
Drugs
ferric derisomaltosetranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on 2016-003087-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003087-40.